Skip to main content
Signal8

Gilead Mobilizes Rapid Donation of Remdesivir to Support Ebola Response, Building on Decade-Long Commitment to Outbreak Relief

$GILDPress releaseJun 12, 2026, 8:30 AM ETRead the release

Gilead Sciences announced a donation of more than 2,000 vials of remdesivir to Uganda to support the response to the current Ebola Bundibugyo virus disease outbreak. The donation is provided under compassionate use and MEURI frameworks, as remdesivir is not approved for filovirus treatment in any country.

Key figures

Donation vials
2000
Patients treated mlcc
8.1 million
Planned us investment
$32 billion
Total patients treated covid
14.5 million

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.